04/16/2024
3:11 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:12 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:13 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:14 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
11:59 AM | AS YOU SOW (Filed by)
Eli Lilly and Company (Subject)
| Form PX14A6G | |
03/28/2024
12:10 PM | Chevedden John (Filed by)
Eli Lilly and Company (Subject)
| Form PX14A6G | |
03/28/2024
11:20 AM | Eli Lilly and Company (Subject)
Trinity Health Corp (Filed by)
| Form PX14A6G | |
|
03/11/2024
3:24 PM | Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
3:26 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:16 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:18 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
10:44 AM | Eli Lilly and Company (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
2:05 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
3:43 PM | Dozier Eric (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:44 PM | Eli Lilly and Company (Issuer)
White Anne E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:34 PM | Eli Lilly and Company (Issuer)
Hakim Anat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:36 PM | Eli Lilly and Company (Issuer)
Skovronsky Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:23 PM | Eli Lilly and Company (Issuer)
Rau Diogo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:25 PM | Eli Lilly and Company (Issuer)
Jonsson Patrik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
10:56 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
8:26 AM | Eli Lilly and Company (Subject)
PNC FINANCIAL SERVICES GROUP, INC. (Filed by)
| Form SC 13G/A | |
02/08/2024
2:34 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
4:08 PM | Eli Lilly and Company (Subject)
| Form FWP | |
02/07/2024
7:12 AM | Eli Lilly and Company (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
02/06/2024
6:04 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
3:32 PM | Eli Lilly and Company (Issuer)
Hakim Anat (Reporting)
Hakim Anat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:20 PM | Eli Lilly and Company (Issuer)
White Anne E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Eli Lilly and Company (Subject)
| Form SC 13G/A | |
01/17/2024
3:15 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:17 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:19 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
2:22 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
3:05 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
1:15 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
2:11 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
5:40 PM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
12/18/2023
5:59 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
12/04/2023
3:17 PM | Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
6:04 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/21/2023
3:27 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:29 PM | Eli Lilly and Company (Issuer)
Runge Marschall S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
11/21/2023
3:15 PM | Baicker Katherine (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:18 PM | Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:20 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:22 PM | Eli Lilly and Company (Issuer)
JACKSON JAMERE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:24 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:53 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/15/2023
5:51 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/08/2023
4:06 PM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/06/2023
5:09 PM | Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
3:25 PM | Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
10:21 AM | Eli Lilly and Company (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
6:02 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/27/2023
3:15 PM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
10/17/2023
3:19 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:21 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:22 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:24 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:15 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:18 PM | Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
5:52 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T | |
10/12/2023
3:00 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
1:06 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023
3:25 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:27 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:28 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:29 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:22 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:24 PM | Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
3:14 PM | Eli Lilly and Company (Issuer)
Weems Alonzo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:26 PM | Eli Lilly and Company (Subject)
Weems Alonzo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
1:37 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2023
12:44 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2023
3:33 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:34 PM | Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:24 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:26 PM | Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:28 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:29 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:31 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
3:00 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
12:31 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2023
2:50 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:34 AM | Eli Lilly and Company (Filed by)
Sigilon Therapeutics, Inc. (Subject)
| Form SC TO-T/A | |
08/09/2023
1:32 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023
8:14 AM | DICE Therapeutics, Inc. (Subject)
Eli Lilly and Company (Filed by)
| Form SC TO-T/A | |
08/08/2023
12:23 PM | Eli Lilly and Company (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
6:01 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
3:46 PM | Eli Lilly and Company (Filed by)
Sigilon Therapeutics, Inc. (Subject)
| Form SC TO-T/A | |
07/25/2023
6:04 AM | DICE Therapeutics, Inc. (Subject)
Eli Lilly and Company (Filed by)
| Form SC TO-T/A | |
07/24/2023
2:55 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Gold Grab of the Century (Ad) When central banks buy gold…
The rich buy right along with them.
And central banks are buying at breakneck pace.
Last year… 1,037 tons.
Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. |
07/21/2023
1:55 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2023
3:33 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:36 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:40 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:43 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:25 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:29 PM | Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:31 PM | Eli Lilly and Company (Filed by)
Sigilon Therapeutics, Inc. (Subject)
| Form SC TO-T/A | |
07/17/2023
4:14 PM | DICE Therapeutics, Inc. (Subject)
Eli Lilly and Company (Filed by)
| Form SC TO-T/A | |
